122 related articles for article (PubMed ID: 34227104)
1. Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Krüppel-like factor 4-dihydropyrimidinase-like 2A (KLF4-DPYSL2A) axis.
Noura M; Morita K; Kiyose H; Okuno Y; Matsuo H; Koyama A; Nishinaka-Arai Y; Kamikubo Y; Adachi S
Br J Haematol; 2021 Aug; 194(3):598-603. PubMed ID: 34227104
[TBL] [Abstract][Full Text] [Related]
2. Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.
Noura M; Morita K; Kiyose H; Matsuo H; Nishinaka-Arai Y; Kurokawa M; Kamikubo Y; Adachi S
Sci Rep; 2020 Nov; 10(1):20245. PubMed ID: 33219287
[TBL] [Abstract][Full Text] [Related]
3. Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.
Matsuo H; Inagami A; Ito Y; Ito N; Iyoda S; Harata Y; Higashitani M; Shoji K; Tanaka M; Noura M; Mikami T; Kato I; Takita J; Nakahata T; Adachi S
Commun Biol; 2024 Jan; 7(1):123. PubMed ID: 38267545
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
5. A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.
Hu S; Ueda M; Stetson L; Ignatz-Hoover J; Moreton S; Chakrabarti A; Xia Z; Karan G; de Lima M; Agrawal MK; Wald DN
Mol Cancer Ther; 2016 Jul; 15(7):1485-1494. PubMed ID: 27196775
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
7. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies.
Christian S; Merz C; Evans L; Gradl S; Seidel H; Friberg A; Eheim A; Lejeune P; Brzezinka K; Zimmermann K; Ferrara S; Meyer H; Lesche R; Stoeckigt D; Bauser M; Haegebarth A; Sykes DB; Scadden DT; Losman JA; Janzer A
Leukemia; 2019 Oct; 33(10):2403-2415. PubMed ID: 30940908
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2.
Britschgi A; Simon HU; Tobler A; Fey MF; Tschan MP
Br J Haematol; 2010 Apr; 149(1):55-64. PubMed ID: 20096012
[TBL] [Abstract][Full Text] [Related]
9. The role of TLR8 signaling in acute myeloid leukemia differentiation.
Ignatz-Hoover JJ; Wang H; Moreton SA; Chakrabarti A; Agarwal MK; Sun K; Gupta K; Wald DN
Leukemia; 2015 Apr; 29(4):918-926. PubMed ID: 25283842
[TBL] [Abstract][Full Text] [Related]
10. Securinine, a myeloid differentiation agent with therapeutic potential for AML.
Gupta K; Chakrabarti A; Rana S; Ramdeo R; Roth BL; Agarwal ML; Tse W; Agarwal MK; Wald DN
PLoS One; 2011; 6(6):e21203. PubMed ID: 21731671
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.
Seipel K; Marques MT; Bozzini MA; Meinken C; Mueller BU; Pabst T
Clin Cancer Res; 2016 Feb; 22(3):746-56. PubMed ID: 26408402
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells.
Lalic H; Dembitz V; Lukinovic-Skudar V; Banfic H; Visnjic D
Leuk Lymphoma; 2014 Oct; 55(10):2375-83. PubMed ID: 24359245
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.
Bunaciu RP; MacDonald RJ; Jensen HA; Gao F; Wang X; Johnson L; Varner JD; Yen A
Leuk Lymphoma; 2019 Jul; 60(7):1697-1708. PubMed ID: 30570341
[TBL] [Abstract][Full Text] [Related]
14. Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression.
Zhang D; Guo Y; Zhao Y; Yu L; Chang Z; Pei H; Huang J; Chen C; Xue H; Xu X; Pan Y; Li N; Zhu C; Zhao ZJ; Yu J; Chen Y
Microb Cell Fact; 2021 Mar; 20(1):67. PubMed ID: 33691697
[TBL] [Abstract][Full Text] [Related]
15. Deregulated expression of Kruppel-like factors in acute myeloid leukemia.
Humbert M; Halter V; Shan D; Laedrach J; Leibundgut EO; Baerlocher GM; Tobler A; Fey MF; Tschan MP
Leuk Res; 2011 Jul; 35(7):909-13. PubMed ID: 21470678
[TBL] [Abstract][Full Text] [Related]
16. Oroxylin A, a natural compound, mitigates the negative effects of TNFα-treated acute myelogenous leukemia cells.
Li H; Lu N; Yu X; Liu X; Hu P; Zhu Y; Shen L; Xu J; Li Z; Guo Q; Hui H
Carcinogenesis; 2018 Oct; 39(10):1292-1303. PubMed ID: 29346508
[TBL] [Abstract][Full Text] [Related]
17. Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cells.
Gao J; Fan M; Xiang G; Wang J; Zhang X; Guo W; Wu X; Sun Y; Gu Y; Ge H; Tan R; Qiu H; Shen Y; Xu Q
Cell Death Dis; 2017 May; 8(5):e2765. PubMed ID: 28471454
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell lines.
Josa-Culleré L; Galan SRG; Cogswell TJ; Jackson TR; Jay-Smith M; Mola L; Greaves CR; Carter TS; Madden KS; Trott S; Zhang D; Bataille CJR; Davies SG; Vyas P; Milne TA; Naylor A; Wynne GM; Russell AJ
Eur J Med Chem; 2023 Oct; 258():115509. PubMed ID: 37343464
[TBL] [Abstract][Full Text] [Related]
19. A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.
Jiang X; Sun L; Qiu JJ; Sun X; Li S; Wang X; So CW; Dong S
PLoS One; 2013; 8(8):e72335. PubMed ID: 23951311
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]